Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis
暂无分享,去创建一个
P. Bhargava | P. Calabresi | E. Mowry | S. Cassard | D. Baer | D. Kapogiannis | K. Fitzgerald | Matthew D. Smith | M. Kornberg | Ellen M. Mowry | Diane Vizthum | Bobbie Henry-Barron | Michael D. Kornberg | Sandra D. Cassard | Patrick Sullivan | Diane Vizthum | Bobbie J. Henry-Barron
[1] P. Bhargava,et al. Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism , 2021, medRxiv.
[2] J. Correale,et al. Obesity and the risk of Multiple Sclerosis. The role of Leptin , 2020, Annals of clinical and translational neurology.
[3] B. Arneth. Contributions of T cells in multiple sclerosis: what do we currently know? , 2020, Journal of Neurology.
[4] L. Bottolo,et al. Leptin-Mediated Changes in the Human Metabolome , 2020, The Journal of clinical endocrinology and metabolism.
[5] J. Smolders,et al. B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers , 2020, Frontiers in Immunology.
[6] P. Sundström,et al. Leptin levels are associated with multiple sclerosis risk , 2020, Multiple sclerosis.
[7] K. Zackowski,et al. Conducting dietary intervention trials in people with multiple sclerosis: Lessons learned and a path forward. , 2019, Multiple sclerosis and related disorders.
[8] J. Goverman,et al. Pathogenic T cell cytokines in multiple sclerosis , 2019, The Journal of experimental medicine.
[9] K. Varady,et al. Differential Effects of Alternate‐Day Fasting Versus Daily Calorie Restriction on Insulin Resistance , 2019, Obesity.
[10] V. Longo,et al. When Fasting Gets Tough, the Tough Immune Cells Get Going—or Die , 2019, Cell.
[11] M. Goldman,et al. Pilot study of a ketogenic diet in relapsing-remitting MS , 2019, Neurology: Neuroimmunology & Neuroinflammation.
[12] D. Zajonc,et al. Self‐glycerophospholipids activate murine phospholipid‐reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading , 2019, European journal of immunology.
[13] P. Bhargava,et al. Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes , 2018, Annals of clinical and translational neurology.
[14] G. Shulman,et al. The circulating metabolome of human starvation. , 2018, JCI insight.
[15] I. Katz Sand. The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence , 2018, Current Nutrition Reports.
[16] M. Kaler,et al. A Pilot Study To Investigate the Immune-Modulatory Effects of Fasting in Steroid-Naive Mild Asthmatics , 2018, The Journal of Immunology.
[17] M. Mattson,et al. Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis. , 2018, Multiple sclerosis and related disorders.
[18] G. Weinstock,et al. Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota. , 2018, Cell metabolism.
[19] D. Priolli,et al. Plasmalogen lipids: functional mechanism and their involvement in gastrointestinal cancer , 2018, Lipids in Health and Disease.
[20] P. Bhargava,et al. Dimethyl fumarate treatment alters NK cell function in multiple sclerosis , 2018, European journal of immunology.
[21] E. Waubant,et al. Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[22] P. Bhargava,et al. Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation. , 2017, JCI insight.
[23] I. Farooqi,et al. A Metabolomic Signature of Acute Caloric Restriction , 2017, The Journal of clinical endocrinology and metabolism.
[24] J. Rood,et al. Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial , 2017, JAMA internal medicine.
[25] W. Gozansky,et al. A randomized pilot study comparing zero‐calorie alternate‐day fasting to daily caloric restriction in adults with obesity , 2016, Obesity.
[26] T. Morgan,et al. A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. , 2016, Cell reports.
[27] J. Rathmell,et al. Leptin Metabolically Licenses T Cells for Activation To Link Nutrition and Immunity , 2014, The Journal of Immunology.
[28] K. Varady,et al. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial , 2013, Nutrition Journal.
[29] K. Varady,et al. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans , 2013, Obesity.
[30] S. Sansano,et al. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus , 2012, Nature Immunology.
[31] G. Schmitz,et al. Plasmalogens the neglected regulatory and scavenging lipid species. , 2011, Chemistry and physics of lipids.
[32] K. Varady,et al. Improvements in Coronary Heart Disease Risk Indicators by Alternate‐Day Fasting Involve Adipose Tissue Modulations , 2010, Obesity.
[33] P. Carrieri,et al. Leptin as a metabolic link to multiple sclerosis , 2010, Nature Reviews Neurology.
[34] L. Piccio,et al. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis , 2008, Journal of leukocyte biology.
[35] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Most,et al. Dietary adherence in well-controlled feeding studies. , 2005, Journal of the American Dietetic Association.
[37] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[38] D. Reich,et al. Multiple Sclerosis , 2018, The New England journal of medicine.